Galera Therapeutics Completes Nova Pharmaceuticals’ Acquisition

Shots: Galera has completed Nova’s acquisition to form Galera Therapeutics, trading on OTC under GRTX ticker. Acquisition was backed by a $3M investment from a group of investors led by Ikarian Capital Galera issued 21.1M common shares, pre-funded warrants for 23M shares & 119,318 Series B convertible preferred shares. At closing, Galera stockholders will…

BySenior EditorJanuary 1, 2025

CXO TALKS

Spotlight Interview: Moreno Perugini in a Candid Conversation with PharmaShots

Following the Reuters Events Pharma USA 2024, PharmaShots brings an engaging conversation with Moreno Perugini, President, of Néstle Health Science. Moreno begins the conversation by highlighting Néstle’s journey to become a full-fledged pharma company through a series of acquisitions and deals. Moreno recalls Néstle’s transitioning into a pharmaceutical company when the company got the rights for Zenpep,…

ByAditya SinghApril 15, 2024

THOUGHTSPOT

Competitive Intelligence: A Substantial Advantage for the Pharmaceutical Sector

“The supreme art of war is to subdue the enemy without fighting” – Sun Zhu, Competitive Intelligence benefits your organization gather and analyzing information related to your competitor’s business models. This deep analysis helps your organization reduce the strategic risks and increase revenue opportunities by attaining deep insights into how the market has changed and…

BySaurabh ChaubeyOctober 11, 2022

Galera Therapeutics Completes Nova Pharmaceuticals’ Acquisition

Spotlight Interview: Moreno Perugini in a Candid Conversation with PharmaShots

Competitive Intelligence: A Substantial Advantage for the Pharmaceutical Sector

Contact US

FOLLOW US